NICOLE ROBICHAUX: Open Payments
NPI 1871600775 · SAFETY HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 83 payments from 21 companies in 2025. Trend: 2023 $2,251 · 2024 $2,163 · 2025 $2,217
Food & beverage: $2,217
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $487 |
| Neurocrine BioSciences, Inc. | 10 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $159 |
| Vanda Pharmaceuticals Inc. | 4 | $141 |
| Teva Pharmaceuticals USA, Inc. | 2 | $138 |
| Noven Therapeutics, LLC | 5 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $116 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| ABBVIE INC. | 5 | $110 |
| Alkermes, Inc. | 5 | $105 |
Products named: REXULTI, INGREZZA, TRINTELLIX, ABILIFY MAINTENA, UZEDY, Xelstrym, CAPLYTA, Auvelity.
Industry payments across FL — which companies pay providers there.
